Home Cart Sign in  
Chemical Structure| 26095-59-0 Chemical Structure| 26095-59-0

Structure of Otilonium bromide
CAS No.: 26095-59-0

Chemical Structure| 26095-59-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Otilonium bromide is an mAchR antagonist used world-wide for the treatment of irritable bowel syndrome.

Synonyms: Octylonium bromide; SP63; Octylonium

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Otilonium bromide

CAS No. :26095-59-0
Formula : C29H43BrN2O4
M.W : 563.57
SMILES Code : CCCCCCCCOC1=CC=CC=C1C(NC2=CC=C(C=C2)C(OCC[N+](CC)(C)CC)=O)=O.[Br-]
Synonyms :
Octylonium bromide; SP63; Octylonium
MDL No. :MFCD00211142
InChI Key :VWZPIJGXYWHBOW-UHFFFAOYSA-N
Pubchem ID :72092

Safety of Otilonium bromide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H332
Precautionary Statements:P280

Isoform Comparison

Biological Activity

Target
  • mAChR

In Vitro:

Cell Line
Concentration Treated Time Description References
Candida albicans 1 μg/mL 4 hours To observe the distribution of ergosterol on the plasma membrane using filipin staining. Results showed that after OTB treatment, the fluorescence of ergosterol on the plasma membrane weakened, while intracellular fluorescence increased, indicating a decrease in ergosterol distribution on the plasma membrane. Adv Sci (Weinh). 2024 Sep;11(35):e2406473
Candida albicans 1 μg/mL 4 hours To investigate the inhibitory effect of OTB on C. albicans and its impact on the expression of ergosterol biosynthesis genes. Results showed that OTB significantly upregulated the expression of ERG1, ERG2, ERG4, ERG5, ERG6, ERG7, ERG9, ERG10, ERG11, ERG12, ERG13, ERG24, ERG25, ERG26, and ERG27 genes. Adv Sci (Weinh). 2024 Sep;11(35):e2406473

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Gastrointestinal C. albicans infection model Intragastric administration 50 mg/kg Administered daily until the end of the observation period To evaluate the therapeutic effect of OTB on invasive candidiasis. Results showed that OTB significantly extended the median survival time of mice (from 5 days to 30 days) and improved the survival rate from 0% to 62.5%. Adv Sci (Weinh). 2024 Sep;11(35):e2406473

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.77mL

0.35mL

0.18mL

8.87mL

1.77mL

0.89mL

17.74mL

3.55mL

1.77mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories